Ca2+ homeostasis is altered in the majority of these patients, manifested predominantly as hypocalcemia, hyperphosphatemia, vitamin D deficiency, FGF23 elevation (coupled with Klotho deficiency) and secondary hyperparathyroidism. The gene discussed is FGF23; the disease is secondary hyperparathyroidism.